On Tuesday October 15, JDRF and PureTech announced the launch of T1D Innovations, an exciting new fund that aims to supply crucial funding for the development of type 1 diabetes therapies. PureTech is a technology development company for start-ups in the healthcare field. Breakthrough T1D has committed $5 million for T1D Innovations, and PureTech will run the fund with the help of Breakthrough T1D leadership and expertise in the field of type 1 diabetes.

The goal in selecting investments is to work with luminaries in the field of type 1 research to move ideas out of the laboratory and onto the road to real patients. About four people will run the fund at PureTech, with lots of input from Breakthrough T1D leaders, including renowned entrepreneur CEO Jeffrey Brewer.

Click here to read the full article.